Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07168785 · ClinicalTrials.gov registry record · Early Phase 1
[18F]-AraG PET Imaging in LA HNSCC
A Early Phase 1 study, sponsored by Indiana University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT07168785 is a Early Phase 1 study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 5 participants.
The verdict
NCT07168785, a Early Phase 1 study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.
Interventions
- DRUG Chemotherapy
- DEVICE Radiotherapy
- DRUG [18F]-AraG radiotracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2027-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07168785
The ClinicalTrials.gov registry entry for NCT07168785 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Chemotherapy is the first listed.
NCT07168785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07168785 about?
NCT07168785 is a clinical study titled "[18F]-AraG PET Imaging in LA HNSCC". This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.
What is the current status of trial NCT07168785?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2025-10-01. Estimated completion is 2027-10.
What interventions are being tested in trial NCT07168785?
The interventions under investigation include: Chemotherapy (DRUG), Radiotherapy (DEVICE), [18F]-AraG radiotracer (DRUG).
Who is sponsoring clinical trial NCT07168785?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.